$rABCL
AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headq...
$0.00
0
$0.00
AbCellera Biologics Reality Metrics
Metric
Show % of Total
Key Facts
Name
AbCellera Biologics Reality
Ticker
rABCL
CUSIP
—
ISIN
—
Platform
Tokenization Type
Tokenization Sponsorship
Third-Party
Type
—
Manager
—
Asset Class
Underlying Assets
—
Eligible Investors
Inception Date
01/01/2026
Use Of Income
—
Management Fees
0%
Performance Fees
0%
Market Data
Total Value
—
NAV
—
Price
—
Token Supply
—
Circulating Supply
—
7D APY
—
30D APY
—
Holders
—
Trailing 30D Active Addresses
—
Monthly Transfer Count
—
Monthly Transfer Volume
—
Tokens
Primary Market
Eligible Investors
Non-U.S. Investor
Base Assets
USDTUSDC
Subscription Time
Instant
Min. Investment
20 USDT
Subscription Fees
0.10%
Subscription Description
—
Redemption Time
Instant
Minimum Redemption Amount
0 USDT
Redemption Fees
0.10%
Redemption Description
—
KYC Description
—
Service Providers
Platform
Manager
—
Sub-Advisor
—
Custodian
Legal Identifier
—
Crypto Custodian
—
Fund Administrator
—
Traditional Broker
—
Crypto Broker
—
Auditor
—
Transfer Agent
—
Paying Agent
—
Legal & Regulatory
Issuer
BG El Salvador
Issuer LEI
—
Issuer CIK
—
Domicile
El Salvador
Regulatory Framework
El Salvador Digital Asset Law (LEAD), U.S. Securities Act Reg. S Exemption
Dispute Resolution Country
—
Account Segregation
—
Bankruptcy Remote
—
Deposit Insurance
—
Terms
—
Fees
Management Fees
0%
Performance Fees
0%
Other Fees
—
Redemption Fees
0.10%
Subscription Fees
0.10%
RWA.xyzAll Rights Reserved